Rep. Rick W. Allen Sells Thermo Fisher Scientific Inc. (NYSE:TMO) Stock

Representative Rick W. Allen (R-Georgia) recently sold shares of Thermo Fisher Scientific Inc. (NYSE:TMO). In a filing disclosed on June 18th, the Representative disclosed that they had sold between $15,001 and $50,000 in Thermo Fisher Scientific stock on May 16th. The trade occurred in the Representative's "R.W. ALLEN & ASSOCIATES, INC. > RWA&A - SECURITIES" account.

Representative Rick W. Allen also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 6/20/2025.
• Purchased $15,001 - $50,000 in shares of Netflix NASDAQ: NFLX on 5/16/2025.
• Sold $15,001 - $50,000 in shares of Thermo Fisher Scientific NYSE: TMO on 4/11/2025.

Thermo Fisher Scientific Trading Up 0.8%

NYSE:TMO traded up $3.58 during midday trading on Friday, hitting $478.61. 4,191,526 shares of the company traded hands, compared to its average volume of 3,108,119. The firm's fifty day moving average is $413.76 and its 200-day moving average is $470.22. Thermo Fisher Scientific Inc. has a 12-month low of $385.46 and a 12-month high of $627.88. The firm has a market capitalization of $180.67 billion, a P/E ratio of 27.68, a P/E/G ratio of 2.47 and a beta of 0.77. The company has a current ratio of 1.93, a quick ratio of 1.38 and a debt-to-equity ratio of 0.65.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.22 by $0.14. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%. The company had revenue of $10.86 billion for the quarter, compared to analyst estimates of $10.68 billion. During the same quarter in the prior year, the firm posted $5.37 EPS. Thermo Fisher Scientific's quarterly revenue was up 2.9% compared to the same quarter last year. On average, sell-side analysts predict that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be given a dividend of $0.43 per share. The ex-dividend date is Monday, September 15th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 0.36%. Thermo Fisher Scientific's dividend payout ratio is currently 10.09%.

Insider Activity

In related news, EVP Gianluca Pettiti sold 300 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $429.93, for a total transaction of $128,979.00. Following the completion of the transaction, the executive vice president directly owned 23,167 shares in the company, valued at approximately $9,960,188.31. This trade represents a 1.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on TMO. Barclays increased their price target on Thermo Fisher Scientific from $450.00 to $490.00 and gave the company an "equal weight" rating in a report on Thursday. Argus cut their price objective on Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Scotiabank raised Thermo Fisher Scientific from a "sector perform" rating to a "sector outperform" rating and set a $590.00 price target on the stock in a research report on Friday, July 11th. Royal Bank Of Canada lowered their price objective on shares of Thermo Fisher Scientific from $651.00 to $637.00 and set an "outperform" rating for the company in a research note on Thursday, April 24th. Finally, UBS Group upped their price objective on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a "neutral" rating in a research note on Thursday. Six investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Thermo Fisher Scientific presently has a consensus rating of "Moderate Buy" and a consensus price target of $593.00.

Institutional Investors Weigh In On Thermo Fisher Scientific

Institutional investors have recently added to or reduced their stakes in the business. Cypress Advisory Group LLC purchased a new position in shares of Thermo Fisher Scientific in the fourth quarter worth about $253,000. Intact Investment Management Inc. raised its stake in shares of Thermo Fisher Scientific by 34.0% in the fourth quarter. Intact Investment Management Inc. now owns 2,600 shares of the medical research company's stock worth $1,353,000 after purchasing an additional 660 shares during the last quarter. Purkiss Capital Advisors LLC purchased a new position in shares of Thermo Fisher Scientific in the fourth quarter worth about $1,121,000. LaFleur & Godfrey LLC raised its stake in shares of Thermo Fisher Scientific by 9.1% in the fourth quarter. LaFleur & Godfrey LLC now owns 29,767 shares of the medical research company's stock worth $15,486,000 after purchasing an additional 2,488 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Thermo Fisher Scientific by 22.0% in the first quarter. GAMMA Investing LLC now owns 4,862 shares of the medical research company's stock worth $2,419,000 after purchasing an additional 877 shares during the last quarter. Institutional investors and hedge funds own 89.23% of the company's stock.

About Representative Allen

Rick Allen (Republican Party) is a member of the U.S. House, representing Georgia's 12th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Allen (Republican Party) ran for re-election to the U.S. House to represent Georgia's 12th Congressional District. He won in the general election on November 5, 2024. Allen was born in Augusta, Georgia, in 1951. He attended Auburn University in Alabama, graduating in 1973 with a B.S. in building construction. After earning his degree, Allen worked as an estimator, project administrator and assistant to the president with a construction firm in Augusta. In 1976, he founded his own construction business, R. W. Allen & Associates, Inc. The company operates in six states across the country. In 2008, Allen was presented with the Augusta Metro Chamber of Commerce’s Small Business Person of the Year award.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.